Implantable cardioverter-defibrillators in patients with long QT syndrome: a multicentre study | Zendy

Agnieszka ZienciukKrajka | Zendy; Maciej Sterliński | Zendy; Artur Filipecki | Zendy; Radosław Owczuk | Zendy; Jacek Bednarek | Zendy; Maciej Kempa | Zendy; Sławomir Sielski | Zendy; Marcin Dziduszko | Zendy; Przemysław Mitkowski | Zendy; Jarosław Kaźmierczak | Zendy; Jacek Kuśnierz | Zendy; Dariusz Michałkiewicz | Zendy; Sebastian Stec | Zendy; Marcin Gułaj | Zendy; Ryszard Majcherek | Zendy; Andrzej Lubiński | Zendy; Grzegorz Raczak | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Implantable cardioverter-defibrillators in patients with long QT syndrome: a multicentre study

Author(s) -

Agnieszka ZienciukKrajka,

Maciej Sterliński,

Artur Filipecki,

Radosław Owczuk,

Jacek Bednarek,

Maciej Kempa,

Sławomir Sielski,

Marcin Dziduszko,

Przemysław Mitkowski,

Jarosław Kaźmierczak,

Jacek Kuśnierz,

Dariusz Michałkiewicz,

Sebastian Stec,

Marcin Gułaj,

Ryszard Majcherek,

Andrzej Lubiński,

Grzegorz Raczak

Publication year - 2018

Publication title -

kardiologia polska

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.527

H-Index - 34

eISSN - 1897-4279

pISSN - 0022-9032

DOI - 10.5603/kp.a2018.0177

Subject(s) - medicine , implantable cardioverter defibrillator , long qt syndrome , sudden cardiac death , population , ventricular fibrillation , adverse effect , cardiology , sinus rhythm , atrial fibrillation , complication , pediatrics , qt interval , environmental health

Implantable cardioverter-defibrillator (ICD) therapy has been proven effective in the prevention of sudden cardiac death, but data on outcomes of ICD therapy in the young and otherwise healthy patients with long QT syndrome (LQTS) are limited.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research